Ringholm, Lene http://orcid.org/0000-0003-2971-8043
Do, Nicoline Callesen
Damm, Peter
Mathiesen, Elisabeth Reinhardt
Funding for this research was provided by:
Novo Nordisk (U1111-1209-6358)
Article History
Received: 4 October 2022
Accepted: 9 October 2022
First Online: 25 October 2022
Declarations
:
: ERM has received fees for giving talks for Novo Nordisk A/S. ERM, PD and LR are participating in multicenter and multinational clinical studies on the use of insulin in pregnant women with pre-existing diabetes in collaboration with Novo Nordisk; no personal honorarium is involved. NCD is funded by Novo Nordisk Foundation.
: The study [CitationRef removed] was in accordance with the Helsinki declaration. In addition, the study was approved by The National Committee on Health Research Ethics (H-15019186 and H-15009413) and The Danish Data Protection Agency (2012-58-0004, RH-2015-289, I-Suite: 04305).
: All participants gave written informed consent before the data collection for the study [CitationRef removed].